Market revenue in 2023 | USD 7.3 million |
Market revenue in 2030 | USD 12.7 million |
Growth rate | 8.2% (CAGR from 2023 to 2030) |
Largest segment | Human donor tissue-derived products |
Fastest growing segment | Human Donor Tissue-Derived Products |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human Donor Tissue-Derived Products, Acellular Animal-derived Products |
Key market players worldwide | 3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological skin substitutes market will help companies and investors design strategic landscapes.
Human donor tissue-derived products was the largest segment with a revenue share of 68.49% in 2023. Horizon Databook has segmented the Brazil biological skin substitutes market based on human donor tissue-derived products, acellular animal-derived products covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil is for the largest medical device market in Latin America and the region is expected to dominate the medical device outsourcing market during the forecast period. Brazil is expected to be the target market for international medical device companies, thereby contributing to the demand for regulatory services during the forecast period.
Brazil’s National Health Surveillance Agency has included regulatory requirements that manufacturing services companies must attain a license as a medical manufacturing unit to maintain quality, safety, and performance parameters. This has made Brazil one of the favorable markets for various foreign manufacturers.
In addition, the growing demand for medical device outsourcing and presence of a stable regulatory system are expected to boost the growth of the region. Brazil follows a four-tier and risk-based classification system. Accurate classification of a product is essential to determine the proper ANVISA regulatory pathway, thereby providing a clear & systematic procedure for outsourcing partners.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil biological skin substitutes market , including forecasts for subscribers. This country databook contains high-level insights into Brazil biological skin substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account